1.,6$h5h1%√∏/*√∏6√∏ 
%(√π(5√∏ 7,%%√∏ √úR√úN√úN ADI 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏ 
.$/√∏7$7√∏)9(.$17√∏7$7√∏)%√∏/(√π√∏0 
Etkin maddesi: 
Her bir litre √ß√∂zelti 100 gram (100 mg/ml) dekstroz i√ßerir. 
Ozmolarite: 555 mOsm/L 
<DUG√ïPF√ïPDGGHOHU 
<DUG√ïPF√ïPDGGHOHULoLQ¬∂HEDN√ïQ√ï] 
)$50$6g7√∏.)250 
√∏QWUDYHQ|]LQI¬Å]\RQLoLQEHUUDNUHQNVL]VWHULOo|]HOWL 
./√∏1√∏.g=(//√∏./(5 
4.1 Terap√∂tik endikasyonlar 
Y√ºksek konsantrasyondaki GHNVWUR]o|]HOWLOHULQLQLQWUDYHQ|]\ROGDQX\JXODQPDV√ï\ODY¬ÅFXGDVX 
YHNDORULVD√∑ODQ√ïU%Xo|]HOWLOHUKDVWDQ√ïQNOLQLNGXUXPXQDJ|UHGL¬ÅUH]LX\DUDELOL U 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏D√∫D√∑√ïGDNLGXUXPODUGDHQGLNHGLU 
'HKLGUDWDV\RQNDUDFL√∑HUGHNLGHSRJOLNRMHQ HNVLNOL√∑LQHED√∑O√ïD√∫√ïU√ïV√ï Y√ïND\E√ïQDED√∑O√ïJHOL√∫HQD√∫√ïU√ï 
NDWDEROLNGXUXPODUN√ïV√ïWO√ïEHVLQYHVXDO√ïP√ïGL\DUHNXVPD\DGDWX] GL¬ÅUH]LQHED√∑O√ïD√∫√ïU√ïV√ïY√ïND\E√ï 
GXUXPODU√ï 
3DUHQWHUDO EHVOHQPH UHMLPOHULQGH NDORUL VD√∑ODPDN DPDF√ï\OD $ √∫D√∑√ïGDNL SDUHQWHUDO EHV lenme 
JHUHNHQGXUXPODUGDD]RWND\E√ïQ√ï|QOHPHN\DGDQHJDWLID]RWGHQJHVLQL G¬Å]HOWPHNLoLQX\JXQELU 
SURWHLQD]RWND\QD√∑√ï\ODELUOLNWHNXOODQ√ïO√ïU 
-$PHOL\DW|QFHVLYHDPHOL\DWVRQUDV√ïG|QHPOHUGH\DGDD√∑√ïUND UDFL√∑HUE|EUHNNDOSYHPLGH -
ED√∑√ïUVDNKDVWDO√ïNODU√ïQGDROGX√∑XJLELD√∑√ï]GDQEHVLQYHVXDO√ïP√ïQ√ïQN√ïV√ïWODQG√ï√∑√ï GXUXPODU 
- Proteinlerin mide- ED√∑√ïUVDNVLVWHPLQGHQHPLOLPLQLQER]XOGX√∑XGXUXPODU 2-3URWHLQOHUHPHWDEROLNJHUHNVLQLPLQLOHULGHUHFHGHDUWW√ï√∑√ï\DQ√ïNOD UYEJLELGXUXPODU 
-√∏QV¬ÅOLQH ED√∑O√ï YH\D ED√∑O√ï ROPD\DQ KLSRJOLVHPL GXUXPODU√ïQGD <HQL GR√∑D Q EHEHN YH V¬ÅW 
oRFXNODU√ïQ√ïQ DNXW VHPSWRPDWLN KLSRJOLVHPLOHULQGH NDQ JOXNR] G¬Å]H\OHULQLQ QRUP DOH 
y√ºkseltilmesi dahil). 
3R]RORMLYHX\JXODPD√∫HNOL 
3R]RORML8\JXODPDV√ïNO√ï√∑√ïYHV¬ÅUHVL 
Uygulanacak doz ve inf√ºzyon K√ï]√ï KDVWDQ√ïQ \D√∫√ïQD D√∑√ïUO√ï√∑√ïQD NOLQLN YH EL\RORMLN GXUXPXQD 
ODERUDWXYDUGH√∑HUOHULQHYHELUOLNWHX\JXODQDQWHGDYL\HJ|UHKHNLPWDUDI√ïQG DQD\DUODQ√ïU 
%D√∫ND ELU LODF√ïQ LQI¬Å]\RQX LoLQ o|]¬ÅF¬Å RODUDN NXOODQ√ïOG√ï√∑√ïQGD VHoLOHFH N KDFLP o|]¬ÅOHUHN 
uygulanacak ila F√ïQ|QHULOHQNXOODQ√ïP√ïQDJ|UHNDUDUOD√∫W√ïU√ïO√ïU 
8\JXODPD V√ïNO√ï√∑√ï KDVWDQ√ïQ NOLQLN GXUXPXQD J|UH KHNLP WDUDI√ïQGDQ D\DUOD Q√ïU +LSHUJOLVHPL 
JHOL√∫LPLQL|QOHPHNLoLQLQI¬Å]\RQK√ï]√ïKDVWDQ√ïQJOXNR]RNVLGDV\RQNDSDVLWHVLQLD√∫PD PDO√ïG√ïU 
Bu nedenle maksimum glukoz uy JXODPDK√ï]√ï -PJNJVDDWROPDO√ïG√ïU 
8\JXODPD√∫HNOL 
8\JXODPDVWHULOVHWOHUOHLQWUDYHQ|]\ROGDQ\DS√ïO√ïU 
8\JXODPD\ODLOJLOLD\U√ïQW√ïODULoLQD\U√ïFDE|O¬ÅP¬∂\DEDN√ïQ√ï] 
g]HOSRS¬ÅODV\RQODUDLOL√∫NLQHNELOJLOHU 
%|EUHN.DUDFL√∑HU\HWPH]OL√∑L 
Bu SRS¬ÅODV\RQD|]HOJHUoHNOH√∫WLULOHQELUoDO√ï√∫PDEXOXQPDG√ï√∑√ïQGDQEXKDVWDJU XEXLoLQ|]HOELU 
GR]DM|QHULVLEXOXQPDPDNWDG√ïU 
Pediyatrik pop√ºlasyon: 
8\JXODQDFDN GR] YH LQI¬Å]\RQ K√ï]√ï HUL√∫NLQOHUGHNL JLEL KDVWDQ√ïQ D√∑√ïUO√ï √∑√ïQD NOLQLN YH EL\RORMLN 
durumuna ve bir OLNWHX\JXODQDQWHGDYL\HJ|UHKHNLPWDUDI√ïQGDQD\DUODQ√ïU 
Geriyatrik pop√ºlasyon: 
8\JXODQDFDN GR] YH LQI¬Å]\RQ K√ï]√ï HUL√∫NLQOHUGHNL JLEL KDVWDQ√ïQ D√∑√ïUO√ï √∑√ïQD NOLQLN YH EL\RORMLN 
GXUXPXQDYHELUOLNWHX\JXODQDQWHGDYL\HJ|UHKHNLPWDUDI√ïQGDQD\DUODQ√ïU 34.3. Kontrendikasyonlar 
+LSHUWRQLNGHNVWUR]o|]HOWLOHULD√∫D√∑√ïGDNLGXUXPODUGDNRQWUHQGLNHGLU 
- Kafa i√ßi veya intraspinal kanamalar. 
-√πLGGHWOLGHKLGUDWDV\RQGXUXPODU√ï 
-$Q¬ÅULGXUXPODU√ï 
- Hepatik koma. 
-0√ïV√ïUYHP√ïV√ïU¬ÅU¬ÅQOHULQHDOHUMLVLROGX√∑XELOLQHQKDVWDODU 
4.4g]HONXOODQ√ïPX\DU√ïODU√ïYH|QOHPOHUL 
3DUHQWHUDOWHGDYLQLQX]DPDV√ï\DGDKDVWDQ√ïQGXUXPXQXQJHUHNWLUGL√∑L] DPDQV√ïY√ïGHQJHVLHOHNWUROLW 
NRQVDQWUDV\RQODU√ï YH DVLW -ED] GHQJHVLQGHNL GH√∑L√∫LNOLNOHUL L]OHPHN LoLQ NOLQLN GH√∑HUOHQGLUPH Y H 
periyodik laboratuvar test OHULQLQ\DS√ïOPDV√ïJHUHNOLGLU 
'HNVWUR]LoHUHQo|]HOWLOHUNHQGLOHULQGHDo√ïNoDYH\DNOLQLNWHIDUN HGLOHPH\HFHNG¬Å]H\GHGL\DEHW 
EXOXQGX√∑XELOLQHQKDVWDODUGDGLNNDWOHNXOODQ√ïOPDO√ïG√ïU 
6RG\XP HNVLNOL√∑L RODQ KDVWDODUGD VRG\XPVX] GHNVWUR] o|]HOWLOHULQLQ LQWUDYH n√∂z inf√ºzyonla 
X\JXODQPDV√ïSHULIHULNNROODSVYHROLJ¬ÅUL\H\RODoDELOLU 
%Xo|]HOWLOHULQX]XQV¬ÅUHOHUOHLQWUDYHQ|]LQI¬Å]\RQODNXOODQ√ïOPDV√ïX\ JXODPD\HULQGHQED√∫OD\DUDN 
\D\√ïODQELUWURPERIOHELWGXUXPXQD\RODoDELOLU 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QLQ ozmolaritesi 555 mOsm/litredir. Hipertonik 
GHNVWUR]o|]HOWLOHULX\JXQELU√∫HNLOGHVH\UHOWLOPHGHQSHULIHULN ELUYHQ\ROX\ODX\JXODQG√ïNODU√ïQGD 
YHQOHUGHLULWDV\RQKDVDUYHWURPER]D\RODoDELOLU%X\¬Å]GHQD√∫√ïU√ïKL SHUWRQLNo|]HOWLOHULQE¬Å\¬ÅN 
bir merkezi vene, ola QDNYDUVDYHQDFDYDVXSHULRUD\HUOH√∫WLULOPL√∫LQWUDYHQ|]ELU NDWDWHU\ROX\OD 
X\JXODQPDODU√ï|QHULOPHNWHGLUg]HOOLNOHNDOS\HWPH]OL√∑LRODQKDV WDODUGDROPDN¬Å]HUHGROD√∫√ïP√ïQ 
D√∫√ïU√ï\¬ÅNOHQPHVLQGHQNDo√ïQPDNLoLQGLNNDWHGLOPHOLGLU%|EUHN\HWPH]OL√∑LRO DQKDVWDOD rda glukoz 
WROHUDQV√ïER]XODELOLU 
+DVWDODUDoRNID]ODPLNWDUGDKLSHUWRQLNGHNVWUR]o|]HOWLVLX\ JXODQPDV√ï|QHPOLELUKLSRNDOHPL\OH 
VRQXoODQDELOLU6HUXPSRWDV\XPG¬Å]H\OHULQHEDN√ïODUDNJHUHNLUVHHNSRWDV\XPX\ JXODQPDO√ïG√ïU 
g]HOOLNOHNDOS\HWPH]OL√∑LRODQKDVWDODUGDROPDN¬Å]HUHGROD√∫√ïP √ïQD√∫√ïU√ï\¬ÅNOHQPHVLQGHQNDo√ïQPDN 
LoLQ GLNNDW HGLOPHOLGLU +LSHUWRQLN GHNVWUR] o|]HOWLOHULQLQ X\JXODQPDV √ï VHUXP HOHNWUROLW 
NRQVDQWUDV\RQXQGDGLO¬ÅV\RQD√∫√ïU√ïKLGUDV\RQNRQMHVWLIGXUXPODUYH\DSXOPRQHU|GHP ROX√∫WXUDFDN 
√∫HNLOGHV√ïY√ïYHYH\DVRO¬ÅW\¬ÅNOHQPHVLQH\RODoDELOLU'LO¬ÅV\RQULV NLHOHNWUROLWNRQVDQWUDV\RQX\OD 4WHUVRUDQW√ïO√ïG√ïU3HULIHULNYHSXOPRQHU|GHPH\RODoDELOHQNRQMHVWLI GXUXPODU√ïQJHOL√∫PHULVNLLVH 
o|]HOWLGHNLHOHNWUROLWNRQVDQWUDV\RQX\ODGR√∑UXRUDQW√ïO√ïG√ïU 
dRN G¬Å√∫¬ÅN GR√∑XP D√∑√ïUO√ïNO√ï \HQLGR√∑DQ EHEHNOHUGH GHNVWUR] HQMHNVL\RQODU√ïQ√ïQ D√∫√ïU√ï \D GD K√ï]O√ï 
X\JXODQPDV√ïVHUXPR]PRODOLWHVLQGHYHRODV√ïEH\LQLoLKHPRUDMLGHDUW√ï√∫DQHGHQROD ELOLU 
%X ¬ÅU¬ÅQ WRNVLN RODELOHQ DO¬ÅPLQ\XP LoHULU 8]XQ V¬ÅUHOL SDUHQWHUDO X\JXO DPDODUGD H√∑HU E|EU ek 
L√∫OHYOHULER]XNVDDO¬ÅPLQ\XPWRNVLNG¬Å]H\OHUHXOD√∫DELOLU3UHPDW¬ÅUH \HQLGR√∑DQODUE|EUHNOHULKHQ¬Å] 
WDPJHOL√∫PHPL√∫ROGX√∑XQGDQYHDO¬ÅPLQ\XPLoHUHQNDOVL\XPYHIRVIRUOXo|]HOWLOH UHJHUHNVLQLPOHUL 
GDKDID]ODROGX√∑XQGDQ|]HOOLNOHULVNDOW√ïQGDG√ïU 
$UD√∫W√ïUPDODU parenteral yoldan g√ºnde 4 - 5 mcg/kg‚Äôdan daha y√ºksek miktarlarda al√ºmin yum alan 
SUHPDW¬ÅU \HQLGR√∑DQODU YH E|EUHN L√∫OHYOHUL ER]XN KDVWDODUGD PHUNH]L V LQLU VLVWHPL YH NHPLN 
WRNVLVLWHVL\OHLOL√∫NLOLG¬Å]H\OHUGHDO¬ÅPLQ\XPELULNLPLROGX√∑XQDL√∫DUHWH WPHNWHGLU 
Biri NLPGDKDG¬Å√∫¬ÅNX\JXODPDK√ï]ODU√ïQGDELOHRODELOPHNWHGLU 
'L√∑HUW√ïEEL¬ÅU¬ÅQOHULOHHWNLOH√∫LPOHUYHGL√∑HUHWNLOH√∫LP√∫HNLO OHUL 
(OHNWUROLW LoHUPH\HQ GHNVWUR] o|]HOWLOHUL HULWURVLWOHUGH DJO RPHUDV\RQ \D GD KHPROL] RODV√ïO√ï√∑√ï 
\¬Å]¬ÅQGHQNDQODELUOLNWHD\Q√ïLQI¬Å]\RQVHWLDUDF√ïO√ï√∑√ï\ODX\JXODQPDPDO√ïG√ïU 
Kortikosteroid veya kortikotropin almakta olan hastalarda hipertonik dekstroz √ß√∂zeltilerinin 
X\JXODQPDV√ï V√ïUDV√ïQGD GLNNDW JHUHNLU d|]HOWLQLQ KLSHUJOLVHPLN HWNL VL GL\DEHWOLOHUGH LQV¬ÅOLQ 
gereksinimlerini GH√∑L√∫WLUHELOLU 
4.6 Gebelik ve laktasyon 
Genel tavsiye 
Gebelik Kategorisi: C 
dRFXNGR√∑XUPDSRWDQVL\HOLEXOXQDQNDG√ïQODU'R√∑XPNRQWURO¬Å.RQWUDVHSVL\RQ
+LSHUWRQLNGHNVWUR]o|]HOWLOHULQLQJHEHNDG√ïQODUGDNXOODQ√ïP√ïQDLOL√∫NLQ \HWHUOLYHULPHYFXWGH√∑LOGLU 
Ha \YDQODU ¬Å]HULQGH \DS√ïODQ oDO√ï√∫PDODU JHEHOLN  YH -YH\D  HPEUL\RQDO  IHWDO JHOL√∫LP  YH -
YH\DGR√∑XPYH -YH\DGR√∑XPVRQUDV√ïJHOL√∫LP¬Å]HULQGHNLHWNLOHUEDN√ïP√ïQGDQ\HWHUVL]GL U%N] 
%|O¬ÅP√∏QVDQODUD\|QHOLNSRWDQVL\HOULVNELOLQPHPHNWHGLU 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏\D√∫DPVDO|QHPLRODQGXUXPODULoLQJHUHNOLROPDG√ïNoD 
JHEHOLNG|QHPLQGHNXOODQ√ïOPDO√ïG√ïU 5Gebelik d√∂nemi 
+D\YDQODU¬Å]HULQGH\DS√ïODQDUD√∫W√ïUPDODUJHEHOLNYH -YH\DHPEUL\RQDOIHWDOJHOL√∫LPYH -veya / 
GR√∑XPYH -YH\DGR√∑XPVRQUDV√ïJHOL√∫LP¬Å]HULQGHNLHWNLOHUEDN√ïP√ïQGDQ\HWH UVL]GLU%N]%|O¬ÅP 
√∏QVDQODUD\|QHOLNSRWDQVL\HOULVNELOLQPHPHNWHGLU 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏ HOGH HGLOHELOHFHN \DUDU√ïQ IHW¬ÅVH RODV√ï ULVNOHULQ 
¬Å]HULQGHROGX√∑XGXUXPODUG√ï√∫√ïQGDJHEHOHUGHNXOODQ√ïOPDPDO√ïG√ïU 
/LWHUDW¬ÅUGHWUDYD\YHGR√∑XPH\OHPLQGHGHNVWUR]YHVRG\XPNORU¬ÅULoHUH Qo|]HOWLOHULQNXOODQ√ïOG√ï√∑√ï 
ELOGLULOPL√∫WLU $QQH YH IHWXVXQ V√ïY√ï GHQJHVL JOXNR] YH HOHNWUROLW NRQVDQW UDV\RQODU√ï LOH DVLW -baz 
dengesi d√ºzenli olarak veya hasta ya da fetusun durumu JHUHNWLUGL√∑L]DPDQGH√∑HUOHQGLULOPHOLGLU 
Laktasyon d√∂nemi 
'HNVWUR]o|]HOWLOHULQLQLQWUDYHQ|]LQI¬Å]\RQXQXQHP]LUPHG|QHPLQGHX\JXODQP DV√ïQ√ïQEHEHNOHU 
¬Å]HULQHELOLQHQELUDGYHUVHWNLVL\RNWXU+HUKDQJLELU√∫¬ÅSKHGXUXPXQGDKDVWDHP]LUPHP HOLGLU 
hUHPH\HWHQH√∑L / fertilite 
'HNVWUR] o|]HOWLOHULQLQ LQWUDYHQ|] LQI¬Å]\RQXQXQ ¬ÅUHPH \HWHQH√∑L ¬Å]HUL QGHNL HWNLOHUL 
DUD√∫W√ïU√ïOPDP√ï√∫W√ïU 
$UDoYHPDNLQHNXOODQ√ïP√ï¬Å]HULQGHNLHWNLOHU 
√∏QI¬Å]\RQ\ROX\ODX\JXODQDQo|]HOWLOHULQNXOODQ√ïP√ïV√ïUDV√ïQGDDUDo NXOODQ√ïP√ïSUDWLN\|QGHQP¬ÅPN √ºn 
GH√∑LOGLU.XOODQ√ïOG√ïNWDQVRQUDDUDoYHPDNLQDNXOODQPD¬Å]HULQGHELOLQHQELUHWNLVL\ RNWXU 
√∏VWHQPH\HQHWNLOHU 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏ KLSHUJOLVHPL\H V√ïY√ï GHQJHVLQGH ER]XNOXNODUD 
KLSHUYROHPL YH HOHNWUROLW G¬Å]H\OHULQGH GH√∑L√∫LNOLNOHUH (hipokalemi, hipomagnezemi ve 
hipofosfatemi) neden olabilir. 
8\JXODPD WHNQL√∑LQH ED√∑O√ï J|U¬ÅOHELOHQ DGYHUV HWNLOHU DUDV√ïQGD IHEU LO UHDNVL\RQODU HQMHNVL\RQ 
\HULQGH HQIHNVL\RQ HQMHNVL\RQ \HULQGH ED√∫OD\DUDN \D\√ïODQ YHQ|] WURPER]  \D GD IOHELW 
ekstravazasyon ve hipervolemi bulunur. 
+LSHUWRQLNo|]HOWLOHULQoRNK√ï]O√ïLQI¬Å]\RQXORNDOD√∑U√ïYHYHQ|]LULWDV\RQD \RODoDELOLU8\JXODPD 
K√ï]√ïKDVWDWROHUDQV√ïQDJ|UHD\DUODQPDO√ïG√ïU8\JXODPDLoLQP¬ÅPN¬ÅQROD QHQJHQL√∫SHULIHULNYHQYH 6RODELOGL√∑LQFH LQFH ELU L√∑QHQLQ VHoLOPHV i √∂nerilir. Bu t√ºr etkilerin erkenden farkedilerek uygun 
WHGDYLOHULQX\JXODQDELOPHVLLoLQX\JXODPDV√ïUDV√ïQGDKDVWDODU√ïQGHYDPO√ïRO DUDNL]OHQPHVLJHUHNLU 
6H\UHOWLOHUHNWRUEDGDNLV√ïY√ï\ODX\JXODQDQHNLODoODU√ïQGDDGYHUV HWNLOHUH\RODoDELOHFH√∑LNRQXVXQGD 
uy DQ√ïNROXQPDO√ïG√ïU%|\OHELUGXUXPGDX\JXODQDQHNLODF√ïQ¬ÅU¬ÅQELOJLVLQHEDN√ïOPDO√ïG√ïU
√∏VWHQPH\HQ HWNLOHULQ J|U¬ÅOPH GXUXPXQGD LQI¬Å]\RQ NHVLOPHOL KDVWD GH√∑H UOHQGLULOPHOL X\JXQ 
WHUDS|WLN |QOHPOHU DO√ïQPDO√ï YH JHUHNOL J|U¬ÅOG¬Å√∑¬ÅQGH WRUEDGD NDODQ o |]HOWL LQFHOH me i√ßin 
VDNODQPDO√ïG√ïU 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QH ED√∑O√ïELOGLULOHQ\DQHWNLOHULoLQ√∫XV√ïNO√ïNV√ïUDOD PDV√ï 
NXOODQ√ïOP√ï√∫W√ïU dRN \D\J√ïQ ¬ï \D\J√ïQ ¬ï LOD  \D\J√ïQ ROPD \DQ ¬ï LOD 
VH\UHN¬ïLODoRNVH\UHN (<1/10.000), bilinmiyor (eldeki verilerden 
hareketle tahmin edilemiyor). 
%D√∑√ï√∫√ïNO√ïNVLVWHPLER]XNOXNODU√ï 
Seyrek: Alerjik reaksiyonlar (√ß√∂zelti i√ßine HNOHQHQLODFDED√∑O√ï 
Bilinmiyor: Anafilaktik reaksiyon; Hipersensitivite 
Metabolizma ve beslenme bozu NOXNODU√ï 
<D\J√ïQ (OHNWUROLWER]XNOXNODU√ïYHKLSHUJOLVHPL 
<D\J√ïQROPD\DQ Hemodil√ºsyon ve hipervolemi. 
'HULYHGHULDOW√ïGRNXER]XNOXNODU√ï 
<D\J√ïQROPD\DQ Terleme. 
*HQHOER]XNOXNODUYHX\JXODPDE|OJHVLQHLOL√∫NLQKDVWDO√ïNODU 
<D\J√ïQROPD\DQ $WH√∫ , titreme, febril reaksiyonlar, enjeksiyon b√∂lgesinin enfeksiyonu 
Seyrek: Tromboflebit 
$UD√∫W√ïUPDODU 
<D\J√ïQROPD\DQ Glukoz√ºri. 
√π¬ÅSKHOLDGYHUVUHDNVL\RQODU√ïQUDSRUODQPDV√ï 
5XKVDWODQG√ïUPD VRQUDV√ï √∫¬ÅSKHOL LODo DGYHUV UHDNVL\RQODU√ïQ√ïQ UDSRUODQPD V√ï E¬Å\¬ÅN |QHP 
WD√∫√ïPDNWDG√ïU5DSRUODPD\DS√ïOPDV√ïLODF√ïQ\DUDUULVNGHQJHVLQLQV¬ÅUHNOL RODUDNL]OHQPHVLQHRODQDN 
VD√∑ODU 6D√∑O√ïN PHVOH√∑L PHQVXSODU√ïQ√ïQ KHUKDQJL ELU √∫¬ÅSKHOL DGYHUV UHDNVL\RQX 7¬ÅUNL\H 
Farmakovijilans Merkezi (T√úFAM)‚Äône bildirmeleri gerekmektedir 7(www.titck.gov.tr; e-posta tufam@titck.gov.tr; Tel: 0 800 314 00 08; Faks: 0 312 218 35 99). 
'R]D√∫√ïP√ïYHWHGDYLVL 
'R]D√∫√ïP√ïQ√ïQWLSLNED√∫ODQJ√ïoL√∫DUHWOHULHNVWUDVHO¬ÅOHUV√ïY√ïGDDUW√ï√∫KLSH UJOLVHPLKHPRJORELQYH 
hematokritte azalma, serum elektrolit konsantrasyo QODU√ïQGDG¬Å√∫PHSRWDV\XPXQK¬ÅFUHOHUGHQ 
HNVWUDVHO¬ÅOHUDUDO√ï√∑DJHoL√∫LYHSOD]PDR]PRODOLWHVLQGHDUW√ï√∫W√ïU
%|EUHNIRQNVL\RQODU√ïQRUPDORODQKDVWDODUGDGR]D√∫√ïP√ï - uygulanan √ß√∂zeltinin hiperozmolaritesine 
ED√∑O√ï RODUDN - az ya da bol bir ozmotik di√ºreze yol a√ßar; buna elektrolitle rin, √∂zellikle de 
SRWDV\XPXQND\E√ïH√∫OLNHGHU 
√∏QI¬Å]H HGLOHQ KLSHUWRQLN NDUERQKLGUDW o|]HOWLOHULQLQ VX ED√∑ODPD NDSDV LWHOHULQLQ ID]OD ROPDV√ï 
QHGHQL\OHGR]D√∫√ïP√ïGXUXPXQGDR]PRWLNGL¬ÅUH]V√ïUDV√ïQGDD]\DGDoRNGHKLGUDWDV\RQROX√∫XU
Dehidr DWDV\RQLONED√∫WDDUWDQSOD]PDR]PRODULWHVLQLQD]DOPDV√ï\OD NDUHNWHUL]HGLU%XQHGHQOHGR] 
D√∫√ïP√ïQGDQKHPHQVRQUDG¬Å√∫HQKHPRJORELQYHKHPDWRNULWG¬Å]H\OHULGL¬ÅUH]V√ï UDV√ïQGDD√∫D√∑√ï\XNDU√ï 
QRUPDOGHQLOHELOHFHNGH√∑HUOHUHJHULG|QHU 
'L¬ÅUH]\DYD√∫JHOL√∫LUVHJOXNR]D√∫√ïU√ïGR]X\ODELUOLNWHPHWDEROL NER]XNOXNODUROX√∫DELOLUEXGXUXP 
|]HOOLNOH ODNWLN DVLW \DS√ïP√ï YH S+ D]DOPDV√ï\OD NDUDNWHUL]H GLU 'L¬ÅUH] ROX√∫PD]VD EX GXUXPGD 
GROD√∫√ïP D√∫√ïU√ï \¬ÅNOHQPHVL\OH LOL√∫NLOL VHPSWRPODU ‚Äì√∂zellikle √∂dem (pulmoner √∂dem dahil)- ve 
intras HO¬ÅOHUSRWDV\XPGDD√∑√ïUELUD]DOPDJ|U¬ÅOHELOLU 
'R]D√∫√ïP√ïQ√ïQWHGDYLVLGR]D√∫√ïP√ïQGDDO√ïQDFDNGL√∑HU|QOHPOHU 
Uygun d√ºzeyde di√ºrez varsa: 
2]PRGL¬ÅUH]OH ND\EHGLOHQ V√ïY√ï YH VSHVLILN HOHNWUROLWOHUL |]HOO LNOH SRWDV\XPX \HULQH NR\PDN 
DPDF√ï\OD VHUXP HOHNWUROLW G¬Å]H\OHULQL V√ïY√ï GHQJHVLQL YH DVLW -baz durumunu s√ºrekli izleyerek 
KDILIoHKLSRWRQLNELUHOHNWUROLWo|]HOWLVLQLQX\JXODQPDV√ï|QHULOLU 
.D\EHGLOHQ V√ïY√ï YH PDM|U HOHNWUROLWOHUL \HULQH NR\PDN LoLQ |QHUL OHELOHFHN ELU o|]HOWLQLQ 
IRUP¬ÅODV\RQX √∫X √∫HNLOGHGLU +HU  PO o|]HOWLGH \DNOD√∫√ïN  PPRO VRG\XP   PPRO 
SRWDV\XPPPRONORU¬ÅU.D\EHGLOHQGL√∑HUHOHNWUROLWOHUGH\HULQHNRQPDO√ïG√ïU 
'L¬ÅUH]OH ND\EHGLOHQ QHW V√ïY√ï YH HOHNWUROLWOHUL \HULQH NR\PDN \ DQ√ïQGD ELU DVLW -ED] GHQJHVL]OL√∑L 
varsa, bu durum da laboratuv DUGH√∑HUOHULV¬ÅUHNOLL]OHQHUHNG¬Å]HOWLOPHOLGLU 82OLJ¬ÅULDQ¬ÅULGXUXPXQGDGR]D√∫√ïP√ïQ√ïQWHGDYLVL 
6RQ oDUH RODUDN NDUERQKLGUDWV√ï] o|]HOWLOHU NXOODQ√ïODUDN SHULWRQ GL\DO L]L \D GD HNVWUDNRUSRUDO 
KHPRGL\DOL]\DS√ïODELOLU 
)$50$.2/2-√∏.g=(//√∏./(5 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QLQ ozmolaritesi 555 mOsm/litredir. 
5.1 Farmakodinamik √∂zellikler 
Farmakoterap√∂tik grup: Parenteral beslenme √ß√∂zeltileri, Karbonhi dratlar 
ATC kodu: B05BA03 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QLQ ozmolaritesi 555 mOsm/litredir. Hipertonik 
GHNVWUR]o|]HOWLOHULY¬ÅFXWWDNDORUL\LYHKLGUDV\RQLoLQJHUHNOLVX \XVD√∑ODUODU%Xo|]HOWLOHUKDVWDQ√ïQ 
NOLQLNGXUXPXQDED√∑O√ïRODUDNGL¬ÅUH]LX\DUDELOLUOHU 
*OXNR] WDPDPHQ PHWDEROL]H RODUDN Y¬ÅFXW SURWHLQ YH D]RW ND\√ïSODU√ïQ√ï D] DOW√ïU JOLNRMHQ 
GHSRODQPDV√ïQ√ï DUWW√ïU√ïU <HWHUOL GR]ODUGD YHULOGL√∑LQGH NHWR]LVL D] DOW√ïU YH\D HQJHOOHU %X QHGHQOH 
y√ºksek konsantrasyondaki glukoz √ß√∂zeltileri esas olarak parenteral b eslenme rejimlerinde kalori 
VD√∑ODPDNDPDF√ï\ODNXOODQ√ïOPDNWDG√ïU 
3DUHQWHUDOEHVOHQPHQLQHQGLNHROGX√∑XDPHOL\DW|QFHVLYHDPHOL\DWVRQUDV√ï G|QHPOHUGH\DGDD√∑√ïU 
NDUDFL√∑HUE|EUHNNDOSYHPLGH -ED√∑√ïUVDNKDVWDO√ïNODU√ïQGDROGX√∑XJLELD√∑√ï]GDQEHVLQYHVXDO√ïP√ïQ√ïQ 
N√ïV√ïWODQG√ï√∑√ï GXUXPODUGD SURWHLQOHULQ PLGH -ED√∑√ïUVDN VLVWHPLQGHQ HPLOLPLQLQ ER]XOGX√∑X 
durumlarda ve protein OHUH PHWDEROLN JHUHNVLQLPLQ LOHUL GHUHFHGH DUWW√ï√∑√ï \DQ√ïNODU  YE JLEL 
GXUXPODUGDD]RWND\E√ïQ√ï|QOHPHN\DGDQHJDWLID]RWGHQJHVLQLG¬Å]HOWPH NLoLQX\JXQELUSURWHLQ 
D]RWND\QD√∑√ï\ODELUOLNWHNXOODQ√ïO√ïUODU 
%XQXQ G√ï√∫√ïQGD KLSRJOLVHPL GXUXPODU√ïQGD GD <HQLGR√∑DQ EHEHN YH V¬ÅW oRFXNODU√ïQ√ï Q DNXW 
VHPSWRPDWLNKLSRJOLVHPLOHULQGHNDQJOXNR]G¬Å]H\OHULQLQQRUPDOH\¬ÅNVHOWLO PHVLGDKLONXOODQ√ïODQ 
KLSHUWRQLN GHNVWUR] o|]HOWLOHUL VD√∑ODG√ïNODU√ï NDORUL \DQ√ïQGD KLGUDV\RQ L oLQ JHUHNOL VX\X GD 
VD√∑ODG√ïNODU√ïQGDQGHKLGUDWDV\RQNDUDFL√∑HUGHNLGHSRJOLNRMHQHNVLNOL√∑LQHED √∑O√ïD√∫√ïU√ïV√ïY√ïND\E√ïQD 
ED√∑O√ïJHOL√∫HQD√∫√ïU√ïNDWDEROLNGXUXPODUN√ïV√ïWO√ïEHVLQYHVXDO√ïP√ï GL\DUHNXVPD\DGDWX]GL¬ÅUH]LQH 
ED√∑O√ïD√∫√ïU√ïV√ïY√ïND\E√ïGXUXPODU√ïQGDGDNXOODQ√ïOPDNWDG√ïU 95.2 Farmakokinetik √∂zellikler 
Glukoz Y¬ÅFXWWDNROD\O√ïNODSLU¬ÅYLNDVLWYH\DODNWLNDVLW\ROXLOHPHWDEROL ]HRODUDNHQHUMLVD√∑ODUYH 
E¬Å\¬ÅNRUDQGDNDUERQGLRNVLWLOHVX\DG|Q¬Å√∫¬ÅU 
Emilim: 
√∏QWUDYHQ|] \ROGDQ X\JXODQDQ LODoODU LoLQGHNL HWNLQ PDGGHOHU X\JXODPD GDQ KHPHQ VRQUD 
maksimum plazma konsantras \RQODU√ïQDXOD√∫√ïU 
'D√∑√ïO√ïP 
*OXNR]VDDWWHJNJ
DNDGDURODQGR]ODUGDJOXNR]¬ÅUL\H\RODoPDNV√ï] √ïQX\JXODQDELOLU(Q\¬ÅNVHN 
LQI¬Å]\RQK√ï]√ïRODQVDDWWHJNJK√ï]√ïQGDX\JXODQDQJOXNR]XQ\DNOD√∫√ïN
LY¬ÅFXWWDNDO √ïU 
Biyotransformasyon: 
Glukoz v√ºcutta NROD\O√ïNODSLU¬ÅYLNDVLWYH\DODNWLNDVLW\ROXLOHWDPDPHQPHWDEROL ]HRODUDNHQHUML 
VD√∑ODUYHE¬Å\¬ÅNRUDQGDNDUERQGLRNVLWLOHVX\DG|Q¬Å√∫¬ÅU 
Eliminasyon: 
*OXNR]XQ EL\RWUDQVIRUPDV\RQX VRQXFX ROX√∫DQ NDUERQGLRNVLW DNFL√∑HUOHUOH VX LVH HVD V RODUDN 
b√∂brekler yoluy ODD]PLNWDUGDLVHWHUIHoHVYHVROXNKDYDV√ï\ODDW√ïO√ïU 
'R√∑UXVDOO√ïNGR√∑UXVDOROPD\DQGXUXP 
LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QLQ ELOH√∫LPLQGHNL JOXNR] Y¬ÅFXWWD HNVLNOLNOHULQL 
WDPDPOD\DFDN RUDQGD \DQL WHUDS|WLN GR]GD YHULOGL√∑LQGH GR√∑UXVDO ELU I DUPDNRNLQHWLN GDYUDQ√ï√∫ 
g√∂sterir. 
5.3 Klinik √∂ncesi g√ºvenlilik verileri 
*OXNR] LQVDQ YH KD\YDQ SOD]PDV√ïQGD QRUPDO ELU ELOH√∫HQ RODUDN EXOXQGX√∑XQGDQ KD\ YDQODUGD 
J¬ÅYHQOLOLNLOHLOJLOLELUDUD√∫W√ïUPD\DS√ïOPDP√ï√∫W√ïU 
d|]HOWLLoLQHNDW√ïODQLODoODU√ïQHPQL\HWLD\U√ïRODUDNGLNNDWHDO√ïQPDO√ïG√ï U 
)$50$6g7√∏.g=(//√∏./(5 
<DUG√ïPF√ïPDGGHOHULQOLVWHVL 
Enjeksiyonluk su 10 6.2. Ge√ßimsizlikler 
d|]HOWL\H HNOHQHFHN LODF√ïQ JHoLPOLOL√∑L |QFHGHQ GH√∑HUOHQGLU LOPHOLGLU *HoLPOLOLN YHULOHULQLQ 
EXOXQDPDPDV√ïGXUXPODU√ïQGDo|]HOWLKHUKDQJLELULODo LOHNDU√ï√∫W√ïU√ïOPDPDO√ï G√ïU 
√á√∂zeltiye ila√ß eklemeden √∂nce LAFLEKS %10 DEKSTROZ dg=(/7√∏6√∏¬∂QGH √ß√∂z√ºnebilir ve 
VWDELOROGX√∑XGR√∑UXODQPDO√ïG√ïU 
6.3. Raf √∂mr√º 
24 ay 
6.4. Saklamaya y√∂nelik √∂zel tedbirler 
¬É&
QLQDOW√ïQGDNLRGDV√ïFDNO√ï√∑√ïQGDGR√∑UXGDQ√ï√∫√ïN almaya QELU\HUGHVDNODQPDO√ïG√ïU 
$PEDODM√ïQQLWHOL√∑LYHLoHUL√∑L 
100, 150, 250, 500 ve 1000 ml‚Äôlik (PP) polipropilen torbalarda. √úr√ºn√ºn setli ve s etsiz olmak √ºzere 
LNLIRUPXEXOXQPDNWDG√ïU 
%H√∫HULW√ïEEL¬ÅU¬ÅQGHQDUWDNDODQPDGGHOHULQLPKDV√ïYHGL√∑HU|]HO √∂nlemler 
.XOODQ√ïOPDP√ï√∫RODQ¬ÅU¬ÅQOHU\DGDDW√ïNPDWHU\DOOHU¬µ¬∂7√ïEEL$W√ï NODU√ïQ.RQWURO¬Å<|QHWPHOL√∑L¬∂¬∂YH 
¬µ¬∂$PEDODM$W√ïNODU√ïQ√ïQ.RQWURO¬Å<|QHWPHOLN¬∂¬∂OHULQHX\JXQRODUDNLPKDHGLOPH OLGLU 
.XOODQ√ïP|QFHVLo|]HOWLNRQWUROHGLOPHOLGLU 
Uygulama steril setlerle in WUDYHQ|]\ROGDQ\DS√ïO√ïU 
<DOQ√ï]FDEHUUDNSDUWLN¬ÅOV¬Å]YHDPEDODME¬ÅW¬ÅQO¬Å√∑¬ÅER]XOPDP√ï√∫¬ÅU¬ÅQOHU NXOODQ√ïOPDO√ïG√ïU 
8\JXODPDVHWL¬ÅU¬ÅQHLOL√∫WLULOGLNWHQVRQUDX\JXODPD\DHQN√ïVDV¬ÅUHGHED√∫ODQP DO√ïG√ïU 
7RUEDGDNLUH]LG¬ÅHOKDYD\DED√∑O√ïRODUDNPH\GDQDJHOHELOHFHNELU hava embolisini √∂nlemek i√ßin, 
ED√∫NDLQI¬Å]\RQV√ïY√ïODU√ï\ODVHULED√∑ODQW√ï\DS√ïOPDPDO√ïG√ïU 
d|]HOWLVWHULOX\JXODPDVHWLDUDF√ïO√ï√∑√ï\ODDVHSWLNWHNQLNNXO ODQ√ïODUDNX\JXODQPDO√ïG√ïU6LVWHPHKDYD 
JLUPHPHVLLoLQX\JXODPDVHWLQGHQNXOODQ√ïP|QFHVLV√ïY√ïJHoLULOPHOLGLU .11 (NLODoODUDVHSWLNNR√∫XOODUGDHQMHNVL\RQXFXQGDQELUL√∑QH\DUG√ïP√ïLOH LQI¬Å]\RQ|QFHVLYHV√ïUDV√ïQGD 
NDW√ïODELOLU 2OX√∫DQ VRQ ¬ÅU¬ÅQ¬ÅQ L]RWRQLVLWHVL SDUHQWHUDO X\JXODPD \DS√ïOP DGDQ |QFH EHOLUOHQPL√∫ 
ROPDO√ïG√ïU 
+DVWD\DX\JXODPDGDQ|QFHHNOHQPL√∫LODF√ïQo|]HOWL\OHW¬ÅP¬Å\OHNDU√ï√∫P√ï √∫ROPDV√ïJHUHNOLGLU(NLODo 
LoHUHQo|]HOWLOHULODoHNOHQPHVLQGHQKHPHQVRQUDNXOODQ√ïOPDO√ïG√ïU GDKDVRQUDNXOODQ√ïOPDN¬Å]HUH 
VDNODQPDPDO√ïG√ïU 
d|]HOWL\HHNLODoNDW√ïOPDV√ï\DGD\DQO√ï√∫X\JXODPDWHNQL√∑L¬ÅU¬ÅQH SLURMHQNRQWDPLQDV\RQXQDED√∑O√ï 
aWH√∫UHDNVL\RQXQDQHGHQRODELOLU$GYHUVUHDNVL\RQJ|U¬ÅOPHVLGXUXPXQGDLQI¬Å] \RQDKHPHQVRQ 
verilmelidir. 
7HNNXOODQ√ïPO√ïNW√ïU 
.√ïVPHQNXOODQ√ïOP√ï√∫ √ß√∂zeltiler VDNODQPDPDO√ïG√ïU 
.√ïVPHQNXOODQ√ïOP√ï√∫WRUEDODU\HQLGHQKDVWD\DX\JXODQDQVLVWHPOHUHED√∑ODQP DPDO√ïG√ïU 
A√ßmak i√ßin: 
'√ï√∫DPEDODM√ïQVD√∑ODPO√ï√∑√ïQ√ïYHV√ï]√ïQW√ïROXSROPDG√ï√∑√ïQ√ïNRQWURO HGLQL]DPEDODMKDVDUJ|UG¬Å\VH 
NXOODQPD\√ïQ√ï] 
.RUX\XFXG√ï√∫DPEDODM√ï\√ïUWDUDNDo√ïQ√ï] 
 .RUX\XFX DPEDODM LoLQGHNL WRUEDQ√ïQ VD√∑ODP ROXS ROPDG√ï√∑√ïQ√ï V√ïNDUDN NRQWU RO HGLQL] 7RUED 
i√ßi QGHNLo|]HOWLQLQEHUUDNO√ï√∑√ïQ√ïYHLoLQGH\DEDQF√ïPDGGHLoHUPHGL√∑LQLNRQWUROHGLQL ] 
8\JXODPDKD]√ïUO√ïNODU√ï 
7RUED\√ïDV√ïQ√ï] 
8\JXODPDXFXQGDNLNRUX\XFXNDSD√∑√ïo√ïNDU√ïQ√ï] 
8\JXODPDVHWLQLQVSD\N√ïQ√ïX\JXODPDXFXQDV√ïN√ïFDEDW√ïU√ïQ√ï] 
4. √á√∂zeltinin KDVWD\DX\JXODQPDV√ïLoLQVHWLQNXOODQ√ïPWDOLPDW√ïQDX\XOPDO√ïG√ïU 
Ek ila√ß ekleme: 
Dikkat: 7¬ÅPSDUHQWHUDOo|]HOWLOHUGHROGX√∑XJLEL¬ÅU¬ÅQHHNOHQHFHNW¬ÅPPDGGHOHU¬ÅU ¬ÅQOHJHoLPOL 
ROPDO√ïG√ïU hU¬ÅQH HNOHPH \DS√ïODFDNVD KDVWD\D X\JXODPDGDQ |QFH VRQ NDU √ï√∫√ïP√ïQGD ge√ßimlilik 
kontrol edilmelidir. 
Uygulama √∂ncesi ila√ß ekleme 
√∏ODoX\JXODPDXFXGH]HQIHNWHHGLOLU 12 2. Eklenecek ila√ß 19- JDXJHNDO√ïQO√ï√∑√ïQGDNLELUL√∑QHVLRODQHQMHNW|UOHWRUEDLoLQHHNOHQLU 
3. d|]HOWLYHLoLQHHNOHQHQLODoL\LFHNDU√ï√∫W√ïU√ïO√ïU Potasyum k ORU¬ÅUJLEL\R√∑XQLODoODUGDWRUEDQ√ïQ 
X\JXODPDo√ïN√ï√∫√ïQD\XNDU√ïSR]LV\RQGD\NHQKDILIoHYXUXODUDNNDU√ï√∫PDV√ïVD√∑O DQ√ïU 
Dikkat: √∏oLQHHNLODoX\JXODQP√ï√∫WRUEDODUVDNODQPDPDO√ïG√ïU 
8\JXODPDV√ïUDV√ïQGDLODoHNOHPH 
6HWLQNOHPSLNDSDW√ïO√ïU 
√∏ODoX\JXODPDXFXGH] enfekte edilir. 
3. Eklenecek ila√ß 19- JDXJHNDO√ïQO√ï√∑√ïQGDNLELUL√∑QHVLRODQHQMHNW|UOHLODoX\JXODPD XFXQGDQ 
X\JXODQ√ïU 
d|]HOWLDVN√ïV√ïQGDQo√ïNDU√ïO√ïUYHWHUVoHYULOLU 
%XSR]LV\RQGD\NHQWRUEDQ√ïQX\JXODPDo√ïN√ï√∫√ïYHHQMHNVL\RQJLUL√∫LQHKDIL IoHYX rularak √ß√∂zelti ve 
HNLODF√ïQNDU√ï√∫PDV√ïVD√∑ODQ√ïU 
7RUED\√ïHVNLNRQXPXQDJHWLUHUHNNOHPSDo√ïO√ïUYHX\JXODPD\DGHYDPHGLOLU 
58+6$76$+√∏%√∏ 
$G√ï 063KDUPD√∏ODo6DQYH7LF$√π 
Adres : 8OD√∫26%0DK'&DG(UJHQH26%1R(UJHQH7HNLUGD√∑ 
8. RUHSAT NUMARASI(LARI) 
249/10 
√∏/.58+6$77$5√∏+√∏58+6$7<(1√∏/(0(7$5√∏+√∏ 
√∏ONUXKVDWWDULKL 14.03.2013
Ruhsat yenileme tarihi: 
.h%¬∂h1<(1√∏/(10(7$5√∏+√∏ 
13 Nisan 2017 13 Nisan 2017 